



Neutrophil swarming delays the growth of clusters of pathogenic 
fungi 
 























Supplementary Table 1: Summary of Swarming Experiments  
The number of individual swarms quantified along with meaning of the error bars in each timepoint and the condition and 
number of donors involved in each experiment are shown. Overall, more than 7,000 swarms were observed over time 
across all experiments. Standard deviation, SD. Standard error, SE. 
Panel Individual Points Error bars 
Number 
of Donors
Figure 1b Average of 24 swarms for 100+, 42 for 100-20 and 29 for the 20-0 groups. SD 2 
Figure 1c 





Figure 1d MK-886 144 swarms SD 3 
Figure 1d U75302 96 swarms from a representative donor SD 3 
Figure 1d PMN 240 swarms SD 3 
Figure 1e 192 swarms per group SD 3 
Figure 2b 40 swarms SD 3 
Figure 2c 40 swarms SD 3 
Figure 2d 104 swarms for all points except 6 and 8 hours, which have 72 SD 3 
Figure 2e C. albicans 182 swarms SD 3 
Figure 2e C. albicans 
yeast locked 
192 swarms SD 3 
Figure 2e C. auris 73 swarms SD 3 
Figure 2e C. glabrata 199 swarms SD 3 
Figure 2e A. 
fumigatus 
48 swarms SD 1 
Figure 3b 68 swarms except the 12 hour point which has 60 swarms SD 3 
Figure 3c 44 swarms SD 3 
Figure 3d 12 swarms SD 3 
Figure 3e 12 swarms SD 3 
Figure 3f 144 swarms except the PMN control group which has 95 swarms SD 3 
Figure 4a DPI 36 swarms SD 3 
Figure 4a Apocynin 48 swarms SD 3 




Figure 4b PMN 288 swarms SD 3 
Figure 4b PMN 
+Trolox 
96 swarms SD 3 
Figure 4b PMN + 
Apocynin 
286 swarms SD 3 
Figure 4b No PMN 219 swarms SD 3 
Figure 4e Control 16 swarms SD 1 
Figure 4e CGD 48 swarms SD 3 
Figure 4f Control 96 swarms SD 1 
Figure 4f CGD 288 swarms SD 3 
Figure 4g 16 swarms SD 1 
Figure 4h 16 swarms SD 1 
Figure 5a 40 swarms SD 3 
Figure 5b 40 swarms SD 3 
Figure 5c 240 swarms SD 3 
Figure 5d 16 swarms from a representative donor SE 4 
Figure 5e 16 swarms from a representative donor SE 4 
Figure 6a 357 swarms for Control, 331 for GCSF and 309 for GM-CSF SD 4 
Figure 6b 40 swarms SD 3 
Figure 6c 40 swarms SD 3 
Figure 6d 285 swarms for Control, 271 for GCSF and 284 for GM-CSF SD 4 
Figure 6e 16 swarms from a representative donor SE 4 
Figure 7a 40 swarms SD 3 
Figure 7b 40 swarms SD 3 
Figure 7c 
256 swarms PMN, 226 Apocynin, 210 GCSF +Apocynin, 208 GM-CSF + 
Apocynin, 233 Candida Alone
SD 3 
Figure 7d 16 swarms from a representative donor SE 4 
Figure 7e 40 swarms SD 3 
Figure 7f 40 swarms SD 3 
Figure 7g 
341 swarms PMN, 355 ABAH, 342 GCSF +ABAH, 349 GM-CSF + ABAH, 
323 Candida Alone 
SD 4 
Figure 7h 
16 swarms from a representative donor, except for GM-CSF and GCSF 
which represent 15 swarms 
SE 4 




Fig S3b 8 swarms from a representative donor SE 3 
Fig S3c 8 swarms from a representative donor SE 3 
Fig S3d 8 swarms from a representative donor SE 3 
Fig S3e 45 swarms SD 3 
Fig S3f 32 swarms for the pmn points, 16 swarms for the C. auris alone points SD 2 
Fig S5b 8 swarms from a representative donor SE 2 
Fig S5c 16 swarms SD 2 
Fig S6c 68 swarms for S. aureus points and 60 swarms for E. coli points. SD 3 
Fig S6d 12 swarms for both S. aureus and E. coli points SD 3 
Fig S6e 12 swarms for both S. aureus and E. coli points SD 3 
Fig S7c 40 swarms SD 3 
Fig S7d 40 swarms SD 3 




Fig S7f Candida 88 swarms SD 3 
Fig S7f Candida +DPI 91 swarms SD 3 
Fig S7f Candida 
+Apocynin 
88 swarms SD 3 
Fig S7f Candida 
+Trolox 
83 swarms SD 3 
Fig S8a 9 wells SE 3 
Fig S9b 24 swarms SD 3 
Fig S9c 64 swarms SD 4 
Fig S9d 64 swarms except for GCSF, which represent 48 swarms SD 4 
Fig S9e 




64 swarms except for NFC1 G5 and A5 treated with apocynin, which 
represent 48 swarms 
SD 4 
Fig S10a 16 swarms SD 1 
Fig S10b 16 swarms SD 1 
Fig S10c 16 swarms SD 1 
Fig S10d Control 16 swarms SE 1 
Fig S10d CGD 48 swarms SD 2 
Fig S10e Control 16 swarms SD 1 
Fig S10e CGD 48 swarms SD 3 
Fig S11a 
16 swarms from a representative donor, except for GCSF which represents 
15 swarms
SE 4 
Fig S11b 16 swarms from a representative donor SD 4 
Fig S11c 16 swarms from a representative donor SE 4 
Fig S11d 16 swarms from a representative donor SD 4 
Fig S11e 16 swarms from a representative donor SE 4 
Fig S11f 16 swarms from a representative donor SD 4 
Fig S11g 16 swarms from a representative donor SE 4 
Fig S11h 16 swarms from a representative donor SD 4 
Fig S11i 
16 swarms from a representative donor for Control, 12 for ABAH, 15 for 
GM-CSF and 14 for GCSF 
SE 4 
Fig S11j 16 swarms from a representative donor SD 4 
Fig S11k 
16 swarms from a representative donor except for GM-CSF which 
represents 15 swarms 
SE 4 





Supplementary Figure 1: Patterning of Live Fungi.  
 
 
Living fungi were patterned in clusters on poly-l-lysine/zetag arrays.  Fungi successfully patterned 
included the yeast of C. albicans, C. glabrata and C. auris as well as the conidia of A. fumigatus (a).  
Fungi incubated on our arrays grew at rates comparable to traditional culture.  C. albicans and A. 
fumigatus forming hyphae that radiated out from the spots and C. glabrata and C. auris covering the 
slides in yeast.  A cartoon model of the assay is shown in (b).  The top row depicts the germination and 
growth of C. albicans when incubated on the arrays alone, while the bottom rows depict the restriction of 
this hyphal growth during human neutrophil swarming. Scale bars represent 100 µm for upper left panel 





Supplementary Figure 2: Dynamics of Human Neutrophil Swarming to C. albicans. 
Individual swarm tracks are shown for the different C. albicans density groups, highlighting the impact of 





Supplementary Figure 3: Yeast-locked Candida Strains and Species Elicit a Reduced Swarming 
Response 
Timelapse imaging shows the progression of neutrophil swarming against wild type C. albicans, yeast-
locked C. albicans or C. glabrata are shown (a). The DAPI channel is presented. Wild type C. albicans 
induces a more robust swarming response. The MFI of Hoechst was quantified and is shown. Average of 
8 swarms from a representative donor is shown (b). Yeast locked C. albicans is controlled more 
 
 
effectively than wild type C. albicans. The MFI of C. albicans was quantified and is shown. Average of 8 
swarms from a representative donor is shown (c). Wild type C. albicans induces a more robust NETosis 
response. The MFI of Sytox Green was quantified and is shown. Average of 8 swarms from a 
representative donor is shown (d). Quantification of the area of fungal growth during incubation of the C. 
glabrata or C. auris with or without neutrophils over time, showing that human neutrophil swarming 
restricts the growth of these fungi (d-e).  N= 45 swarms across three different donors for C. glabrata (e).  
N=32 swarms for the “with neutrophils” group and N=16 spots for the C. auris alone group, across 
experiments with two different donors (f).  Error bars represent mean +/- standard error for b-d and mean 
+/- standard deviation for e-f. Scale bar is 100 µm. 
  
 
 Supplementary Figure 4: Staining of NETs in Human Swarms 
Human neutrophils were allowed to swarm against C. albicans for 5 hours. Swarms were then stained, 
without fixation, to show DNA (Sytox Green) and citrullinated histone H3. Swarms stained with 
secondary antibody but no primary antibody served as a control. Images represent maximum image 




Supplementary Figure 5: DNase Effectively Degrades NETs During Swarming and Allows Candida 
Growth 
Timelapse imaging shows the progression of swarming in the presence of DNase (200U). BF, DAPI 
(Hoechst) and FITC (Sytox Green) channels are shown (a). The FITC channel is shown for a swarm 
without DNase treatment as a comparison (fourth row). DNase degrades NETs. The MFI of Sytox Green 
staining was quantified for swarms with and without 200U of DNAase treatment. Average of 8 swarms 
from a representative donor is shown (b). NETs contribute to the expansion of the swarm at later 
timepoints. The area of the swarm was quantified over time for swarms with and without DNase 
 
 
treatment. N= 16 swarms across two donors (c). ** p= 0.0077 and ***p= 0.0004 One way ANOVA with 
Tukey’s post-test. Error bars represent mean +/- standard error for (b) and mean +/- standard deviation for 
(c). Scale bar represents 100 µm. 
 




Human neutrophils were incubated with microbial particle arrays, including those derived from S. aureus 
and E. coli.  Representative panels from a time-lapse showing the progression of neutrophil swarming to 
S. aureus or E. coli are shown, including the bright-field and DAPI (Hoechst staining) channels (a-b).  
The area of neutrophil swarms around S. aureus and E. coli particles (c), along with the number of nuclei 
(d) and the number of nuclei/µm2 (e) was also quantified. N=68 swarms for S. aureus and N=60 swarms 
for E. coli across three donors for the areas (c).  N=12 swarms for d and e. Error bars represent mean +/- 

























Supplementary Figure 7: ROS Inhibition by Apocynin and DPI Results in Opposing Phenotypes 
Human neutrophils were incubated with ROS inhibitors to interrogate the mechanisms necessary to 
restrict the growth of C. albicans during swarming.  Human neutrophil swarming is regulated by reactive 
oxygen species. Apocynin (300 µM) disrupted the ability of neutrophils to swarm to C. albicans, while 
the inclusion of DPI (10 µM) resulted in rapid formation and then dissolution of swarms, as shown in a 
representative series of image panels (a-b). C.albicans within swarms treated with Apocynin germinate 
faster than in vehicle treated control swarms. N= 40 swarms across 3 donors (c). Fungal hyphae 
penetrated and escaped containment by neutrophil swarms faster during Apocynin treatment. N= 40 
 
 
swarms across 3 donors (d). The inhibition of ROS production significantly disrupted the ability of 
swarming to restrict C. albicans growth. The growth of C. albicans during swarming, as measured by 
expression of a far-red fluorescent protein, is shown in the presence of different ROS inhibitors (e). The 
area of fungal growth when C. albicans is incubated with the ROS inhibitors without neutrophils is also 
shown, demonstrating that DPI has a direct impact on C. albicans (f). N=88 spots for C. albicans only 
and C. albicans + APocynin, N=83 spots for C. albicans + Trolox and N=91 spots for C. albicans +DPI. 
****p <0.0001 Students T-test (unpaired, two-tailed) for c,d and Kruskal-Wallis with Dunns multiple 












Supplementary Figure 8: Validation of NCF1 KO Cells 
NCF1 KO clones were validated by functional assays and by Western Blot. NCF1 deficient clones are 
severely defective in ROS production during incubation with C. albicans heat-killed hyphae. Total 
lucigenin luminescence corresponds with ROS production (AU, arbitrary units).  N=9 wells pooled from 
3 independent runs (a). Western blotting of NCF1 protein comparing parental Cas9 control neutrophils 
and NCF1 knockout ER-HoxB8 neutrophils generated using CRISPR-Cas9. Western blot confirmed the 
loss of NCF1 protein in the mature neutrophil cell lines (b). β-actin serves as a standard protein loading 
control. *p = 0.0106, n.s. is non-significant Kruskal-Wallis with Dunns post-test. Error bars represent 









Control or NCF1 deficient mouse neutrophils matured from the Hoxb8 cell system were added to 
swarming arrays of C. albicans, exactly as described for human cells. Representative panels are shown 
from a timelapse showing the progression of swarming by control or NCF1 deficient neutrophils, 
including brightfield and DAPI (Hoechst staining) channels (a). The area of the neutrophil swarm was 
quantified at specified time points duing the assay (b). N=24 swarms across three independent runs. The 
area of fungal growth was quantified at 10.5 hours into the assay and normalized to the growth of C. 
albicans alone (c-f). ROS inhibition by apocynin or NCF1 deficiency results in significantly more fungal 
growth than during control swarming. N= 64 swarms across 4 independent runs (c). Treatment of mouse 
HoxB8 control cells with GM-CSF or GCSF can partially rescue antifungal action during apocynin 
treatment. N= 64 swarms except for the Apocynin GCSF group for which N=48 swarms across 4 
independent runs (d). Treatment of NCF1 deficient neutrophils can partially rescue antifungal action. N= 
64 swarms except for G5 GCSF, A5 GM-CSF and A5 GCSF for which N=48 across 4 independent runs 
(e). Treatment of NCF1 deficient cells with apocynin has no significant impact on antifungal control. 
N=64 swarms except for G5 and A5 Apocynin groups for which N=48 swarms across 4 independent runs 
(f). ****p<0.0001 One way ANOVA with Tukeys post-test for b-d and f or Kruskal-Wallis with Dunns 















Supplementary Figure 10: Individual CGD Sample Profiles 
CGD neutrophils exhibit increased swarming at early timepoints, though the extent is variable. The area 
of neutrophil swarms were quantified and shown for each CGD sample individually (a-c, the pooled 
results can be seen in Fig 4e). N=16 swarms for healthy donor and for each CGD sample except for CGD 
timepoints 240-720 for sample#2 and 120-720 for sample#3, for which N=15 swarms. CGD samples 
show reduced NET release. The MFI of Sytox Green staining was quantified for swarms from a healthy 
donor and from CGD neutrophils (d). The average is shown for 16 swarms from a healthy donor and 48 
swarms across three CGD samples. The number of nuclei/µm2 was quantified and is shown (e). N=16 
swarms for healthy donor and 48 swarms across three CGD samples. *p≤0.05 (p=0.0267 for a, p=0.0388 
for c) **p≤0.01 (p=0073 for a), ***p≤0.001 (p= 0.0001 for control 300 vs CGD 300 and p=0.0007 for 
 
 
control 360 vs CGD 360 in c), ****p <0.0001 (c, e). Kuskal-Wallis with Dunn’s post-test a-c; Mann-
Whitney for f (unpaired, two-tailed). Error bars represent mean +/- standard deviation except for d, which 
represents mean +/- standard error.   
 
 
Supplementary Figure 11: GM-CSF or GCSF Boost Swarming but not NET Release Profiles   
GM-CSF and GCSF treatments accelerate swarming responses, increase the number of neutrophils, and 
have minimal impact on NET release. The MFI of Hoechst stained neutrophils was quantified over a 14 
hour swarming assay (a, e, i). The slope of each profile over the first hour (b) or 4 hours of the assay (f, j), 
indicated by a red box, was determined and plotted. Sytox green MFI was quantified over a 14 hour 
swarming assay (c, g, k). The slope of each profile over the whole 14 hour assay was determined and 
plotted (d, h, l). N=16 swarms from a representative donor except for GCSF, ABAH GM-CSF for which 
N=15, ABAH GCSF for which N=14 and ABAH for which N=12 (a-l). n.s. is non-significant, *p ≤0.05 
(p= 0.0117 for ABAH PMN vs GM-CSF and p= 0.0002 ABAH vs GCSF in j), **p ≤0.01 (p= 0.0015 for 
Apocynin PMN vs GM-CSF and p= 0.0002 for Apocynin vs GCSF in f,). ***p≤ 0.001 (p= 0.0005 for 
control vs GM-CSF and p< 0.0001 for control vs GCSF in b). Kruskal-Wallis with Dunn’s multiple 
comparisons test b, f. One way ANOVA with Tukeys post-test d, h, j, l. Error bars represent mean +/- 
standard deviation (b, d, f, h, j, l) or mean +/- standard error (a, c, e, g, I, k). 
 
